Liquid biopsy-A biomarker-based revolutionising technique in cancer therapy

被引:0
|
作者
Sarkar, Subham [1 ]
Chakraborty, Samraggi [2 ]
Ghosh, Soubhagya [3 ]
Chowdhury, Ekanansha Roy [4 ]
Rajak, Jenifer [3 ]
Mitra, Arup Kumar [3 ]
Kumer, Ajoy [5 ]
Dhara, Bikram [6 ,7 ]
机构
[1] St Xaviers Coll Autonomous, Dept Biotechnol, Postgrad & Res, Kolkata, India
[2] Univ Calcutta, SN Pradhan Ctr Neurosci, Kolkata, India
[3] St Xaviers Coll Autonomous, Dept Biotechnol, Postgrad & Res, Kolkata, India
[4] Univ Engn & Management, Dept Biotechnol, Kolkata, India
[5] IUBAT Int Univ Business Agr & Technol, Dept Chem, Dhaka, Bangladesh
[6] Saveetha Inst Med & Tech Sci, Saveetha Med Coll & Hosp, Ctr Global Hlth Res, Chennai, India
[7] Novel Global Community & Educ Fdn, Dept Hlth Sci, Sydney, NSW, Australia
来源
CLINICAL AND TRANSLATIONAL DISCOVERY | 2024年 / 4卷 / 05期
关键词
cancer biomarkers; enzyme-linked immunosorbent assay; liquid biopsy; next-generation sequencing; polymerase chain reaction; METHYLATION;
D O I
10.1002/ctd2.70006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and AimsCancer has grabbed the attention of scientists and medical professionals all over the world much more than any other disease. In the past few decades, the medical field has improved quite a lot but progress in the path to find a solution for cancer is very less. As the popularity of invasive technologies is diminishing in cancer treatment, scientists have come up withminimally invasive or non-invasive alternatives, among which liquid biopsy, by far is the most suitable.MethodsLiquid biopsy is used to analyse nucleic acids, subcellular components and circulating tumour cells in various biological fluids for diagnosis of cancer. It can also be used to know the efficacy of cancer drugs in a patient by analysing multiple samples.OutcomesLiquid biopsy is becoming standard of care as it allows biopsy of those samples in which solid tumour biopsies are not possible. The diversity of sampling procedures, such as collection of urine for urothelial carcinoma or bladder or prostate cancer and phlebotomy for other types of cancer, make liquid biopsy one of the best methods for diagnosis of cancer.ConclusionThis review aims in discussing the several techniques used for the detection of cancer biomarkers and some clinical manifestations due to the changes in the biomarkers which are analysed by liquid biopsy. Liquid biopsy analyses the levels of biomarkers, which are of clinical significance present in bodily fluids like blood, serum, urine and saliva for diagnosis of cancer. The different biomarkers evaluated by liquid biopsy include cell-free DNA, circulating tumour DNA, non-coding RNA, proteins, exosomes and circulating tumour cells. The biomarkers are analysed using different sophisticated techniques such as microarray, next-generation sequencing, microfluidics, karyotyping, advanced microscopy and fluorescence in situ hybridisation. The biomarkers provide valuable information regarding the stage of cancer and also enlightens medical professionals about the most suitable therapy. image
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Personalized Therapy and Liquid Biopsy-A Focus on Colorectal Cancer
    Christou, Niki
    Veyrune, Lea
    Popeskou, Sotirios Georgios
    Mathonnet, Muriel
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (07):
  • [2] Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer
    Jong-chan Lee
    Sung Won Kang
    Eun-Jin Sim
    Jin-Sik Bae
    Seong-mo Koo
    Mun-sub Byoun
    Serin Kwon
    Seoi Hong
    Yunji Kim
    Yuna Youn
    Kwangrok Jung
    Jaihwan Kim
    Hyoung Hwa Jeong
    Jihie Kim
    Jin-Hyeok Hwang
    BMC Cancer, 25 (1)
  • [3] BIOMARKER-BASED CANCER THERAPY PERSONALIZATION
    Yamada, T.
    Masuda, M.
    Honda, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 54 - 54
  • [4] Biomarker-based selection of therapy for colorectal cancer
    Ross, Jeffrey S.
    BIOMARKERS IN MEDICINE, 2011, 5 (03) : 319 - 332
  • [5] Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
    Qin, Xian-Yang
    Mendoza-Parra, Marco Antonio
    Shirakami, Yohei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer Current Perspective
    Ross, Jeffrey S.
    Torres-Mora, Jorge
    Wagle, Nikhil
    Jennings, Timothy A.
    Jones, David M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 478 - 490
  • [7] MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy
    Kawakami, Hisato
    Okamoto, Isamu
    GASTRIC CANCER, 2016, 19 (03) : 687 - 695
  • [8] MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy
    Hisato Kawakami
    Isamu Okamoto
    Gastric Cancer, 2016, 19 : 687 - 695
  • [9] Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
    Cohen, Joshua D.
    Javed, Ammar A.
    Thoburn, Christopher
    Wong, Fay
    Tie, Jeanne
    Gibbs, Peter
    Schmidt, C. Max
    Yip-Schneider, Michele T.
    Allen, Peter J.
    Schattner, Mark
    Brand, Randall E.
    Singhi, Aatur D.
    Petersen, Gloria M.
    Hong, Seung-Mo
    Kim, Song Cheol
    Falconi, Massimo
    Doglioni, Claudio
    Weiss, Matthew J.
    Ahuja, Nita
    He, Jin
    Makary, Martin A.
    Maitra, Anirban
    Hanash, Samir M.
    Dal Molin, Marco
    Wang, Yuxuan
    Li, Lu
    Ptak, Janine
    Dobbyn, Lisa
    Schaefer, Joy
    Silliman, Natalie
    Popoli, Maria
    Goggins, Michael G.
    Hruban, Ralph H.
    Wolfgang, Christopher L.
    Klein, Alison P.
    Tomasetti, Cristian
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Lennon, Anne Marie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (38) : 10202 - 10207
  • [10] Biomarker-Based Early Cancer Detection: Is It Achievable?
    Hazelton, William D.
    Luebeck, E. Georg
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (109)